Form 4: Surrozen Executive Yang Li Reports Stock Option and RSU Grant

Yang Li, Executive Vice President of Research at Surrozen, Inc., reports the acquisition of stock options and restricted stock units (RSUs).

Summary

• Yang Li, the Executive Vice President of Research at Surrozen, Inc., filed a Form 4 with the SEC.
• The filing reports the acquisition of 10,000 stock options with an exercise price of $8.97 on April 24, 2024.
• These options vest in 48 equal monthly installments starting February 1, 2024, and expire on April 24, 2034.
• Li also acquired 5,000 restricted stock units (RSUs) on April 24, 2024.
• The RSUs vest in two equal installments on January 1, 2025, and January 1, 2026.
• Following these transactions, Li directly owns 10,000 stock options and 5,000 RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard executive compensation practices, indicating confidence in the company's future, but doesn't contain any groundbreaking news.

Positives

• The grant of stock options and RSUs to a key executive like Yang Li can be seen as an incentive to align their interests with the company's long-term success.
• The vesting schedules encourage continued service and commitment from the executive.

Industry Context

This filing is a routine disclosure of insider transactions, common in publicly traded companies to ensure transparency and prevent insider trading. It reflects part of the company's compensation strategy to incentivize key employees.

Comparison to Industry Standards

• Stock option and RSU grants are a standard component of executive compensation packages in the biotechnology industry.
• Companies like Amgen, Gilead, and Regeneron routinely grant stock options and RSUs to their executives as part of their overall compensation strategy.
• The vesting schedules described in the document are typical for such grants, aligning executive incentives with long-term company performance.

Stakeholder Impact

• Shareholders may view the grants as a positive sign, aligning executive interests with company performance.
• Employees may see this as a positive indicator of the company's commitment to its leadership.

Key Dates